National Academies Press: OpenBook
« Previous: Appendix B
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page111
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page112
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page113
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page114
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page115
Suggested Citation:"Appendix C." Institute of Medicine. 2001. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10208.
×
Page116

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix C Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2001, AAP, 1999)

Ad ~ - A) v: a: o ~ - N As i_ o o - V o C) - ~: o V, S: ·_ C) V - Em ~ 1~ e:^ ~ ~= ~= ~~)~ 555 E e o-5 = it= _ s ·,O ~ = - o, a Cal 3 _ '_ U. 3 ~0 - ¢,, 1~, ~ =, 3 ~ O ~ ~ ~ O ~ ~ O _ _ o Z Z to V O —O—— O O O 0 00 Ct O C) ~ 'C) X ~ Ct 3 ~ ~ ~ .~ U., ~ X ~ ~ c: 3 z E .= X ~ =, ~ o o rs U) m .= ~ ~ ~ ~ ~ ~ D : - ~ ~ ~ i'8 ~ ~o O O O ~ <1 _ Z Z <> O 00 ~ ~0 7 O O O O O O. O. . O O 3 ~ ~ ~ << ~ U. , U. _ ~ '_ ~ C,) ~ C) <: 3 <~ .. ~ ~ e ~ :~ ~ e, :: 0 Q41 =~3 2' ~ 3 ~ ~ ~ ~g _ C C~ 4, ._ o qe, oo o Z ~ C =~!

~ o v ~ o o o o v - - £ x ~ Ct Cat ? - 2 X 2 C C~ C E A, ~ m ~ ~ := a_ 0 0 z <,^ no ;. Ceder O O ~ ~ US ~ O - ~S o ·E s ._ o V z Cal s ·C~ o s ·_ s V a a · ;^ L4 V of 0 0 0 0 0 0 of 0 0 of 0 0 ~O U. U3 == ~ ~ X _ X ~ ~ e ~ :E S :: o .~ ._ - 8 s - v I: C) C, ~: L. - ~ v s o - - o z ~a · - ~z o. o Q) - .- ~3 3 ° CC s~ b0 o O Z ~ o Pa = ~: * ~ ~ 3 ~ U. ·E o Ct o ~D C, - c) Ct s C) * ~ -6] 18 ~ ~ U., 6 o o U. w ;^ c c o >` o - ~C C~ . C, c ec :> U. c :C oo V~ - ~ o o o ,, ~o . _ {C - _ _ o, o ~ .= .= o t ~ Q ~ W . o oo ~,. ~ o 3 ~ ° ^e .U' ~W7 ~ ° , o ~ ~ C) = ~ ~ ~ 6 . C ~ ~ 4,, _ 0 ·° ' ~ c =0 O ~ - - ~ ~ _ C E ~ ~ ,..= at < 2 ~ Z ~ ~ . ~ ~ Z

115 IMMUNIZE TION SAFETYREVIEW TABLE C-2 Currently Licensed Vaccines That Are Recommended for Some Children Current Thimerosal Content (June 2001) Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/05mL DT All Products Lederle 0.01 25 (Dipithe asthma toxoid) TT All Products Lederle 0.01 25 (Tedious Toxoid) Hepatitis A Havrix A SmithKline Beecham 0 0 Vaqta Merck 0 0 Influenza All Aventis Pasteur, 0.01 25 Medeva, and Led erl e- Wyeth NOTE: The formulation of vaccines listed in C-2 and C-3 have not changed since August/September 1999. TABLE C-3 Over Licensed Vaccines in the United States Current Thimerosal Content (June 2001) Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/0~5mL Anthrax Anthrax BioPort Corporation 0 0 Vaccine BCG N/A N/A . . Hepatitis A- Twinrix Glaxo-SmithKline 0 0 Hepatitis B Hepatitis B Engerix B Glaxo-SmithKline 0.00S 12.5 (~/tfonn~Jotion) Recombivax Merck 0.005 12.5 HE (it fo~lat~on) Lyme LYMErix Glaxo-SmithKline 0 0 Meltings Menomune A, Aventis Pasteur 0.01 25 coccal6 C, AC and A/C/YM[-1 35 Rabies MOVAX Aventis Pasteur 0 0 Rabavert Chiron 0 0 Rabies Vaccine Bioport Corporation N/A N/A Adsorbed7 Typhoid Typhim Vi Aventis Pasteur 0 0 Fever Typhoid Ty21a V~votefBema 0 0 Typhoid Vac- Wyeth-Ayerst 0 0 cine Yellow Y-F-Vax Aventis Pasteur 0 0 Fever 6 Menomunc AJC/YIW-135, a thimerosal-containing vaccine, is not indicated for infants and children younger teal? 2 yews of age except as short-tenn protection of infants 3 months and older against Group ~ (Physician 's Desk Reference, 2001). ' This vaccine is no longa available but did contain 0.01% thimerosal ( 25 fig Hg/O.SmL). N/A means that the product is no longer currently produced or distributed in We United States.

Next: Appendix D »
Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders Get This Book
×
Buy Paperback | $45.00 Buy Ebook | $35.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In this report, the Immunization Safety Review committee examines the hypothesis of whether or not the use of vaccines containing the preservative thimerosal can cause neurodevelopmental disorders (NDDs), specifically autism, attention deficit/hyperactivity disorder (ADHD), and speech or language delay.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!